Gary H. Wimbish, Ph.D., DABFT Forensic Toxicology Consultants, Inc. 609 Cosby Road Milford, TX 76670 POSITION: President Forensic Toxicology Consultants, Inc. EDUCATION: B.S.: Ph.D.: (Chemistry) Texas A&M University College Station, Texas 1966 (Toxicology) Indiana University Medical Center Indianapolis, Indiana 1973 Fellow: American Academy of Forensic Sciences, 1975 Certification: American Board of Forensic Toxicology Diplomate 1977, Recertified 1985, 1990, 1995, 2000, 2005, 2010 Certificate #36 Qualified Laboratory Director New York State Department of Health - Toxicology Laboratory Inspector College of American Pathology F.U.D.T. Program Laboratory Inspector S.A.M.H.S.A. Program Inactive May 2001 NHTSA/IACP Standard Field Sobriety Test Practitioner 2003 NHTSA/IACP Standard Field Sobriety Test Instructor 2005 RECERTIFICATIONS: NHTSA/IACP Standard Field Sobriety Test Practitioner 2008 NHTSA/IACP Standard Field Sobriety Test Practitioner 2011 NHTSA/IACP Standard Field Sobriety Test Practitioner 2012 PROFESSIONAL EXPERIENCE: 1995 Oct. 1 Present President, Forensic Toxicology Consultants, Inc. 609 Cosby Road, Milford, TX 76670 1996 Nov. 1 May 1, 1998 Laboratory Director, R.P. Harrison Laboratories 9930 W. Hwy 80, Midland, TX 79706
1992 Mar. Sept 1999 Adjunct Associate Professor of Pharmacology 1991 Jan. Oct. 1, 1995 Laboratory Director Laboratory Specialists, Inc. Belle Chasse, LA 70037 1990 Oct, - Jan 1991 Associate Professor of Pharmacology 1976 Oct, 1990 Associate Professor of Pathology 1979 Oct. 1990 Director, Institute of Forensic Medicine 1987 1988 Chairman (Ag), Department of Pathology 1977 1991 Associate Professor and Member of Graduate Faculty University of North Texas Denton, TX 76201 1989 1990 National Scientific Director Laboratory Specialists, Inc. Belle Chasse, LA 70037 1990 1991 Consulting Toxicologist to Laboratory Specialists, Inc. Belle Chasse, LA 70037 1989 Present Laboratory Director Quemetco Laboratories/Sea Harbor Laboratories RSR Corporation, Dallas, TX 75207 1976 1989 Consultant Toxicologist to Damon Clinical Laboratories Irving, TX 75057 1986 1989 Laboratory Director American Institute for Drug Detection (AIDD) Dallas, TX
1973 1975 Director, Department of Toxicology Pathology Associates of Texas Fort Worth, TX 76104 1968 1969 Consultant to Southern Lead Company (RSR) Dallas, TX 75207 1966 1969 Forensic and Analytic Chemist Terrell s Laboratory Fort Worth, TX 1965 1966 Pesticide Residue Chemist Department of Entomology/Toxicology Texas A&M University HONORS AND AWARDS: 1969 1973 Fellowship. Indiana University Medical Center Indianapolis, Indiana 1979 Outstanding Citizen of Fort Worth PROFESSIONAL SOCIETIES: SERVICE (COMMUNITY) SOCIETIES: TEACHING EXPERIENCE: Diplomate, American Board of Forensic Toxicology The International Association of Forensic Toxicologists American Chemical Society 1967 1998 The American Academy of Forensic Sciences, Fellow Southwestern Association of Toxicologists, Charter Member Society of Forensic Toxicologists, Sigma XI Fort Worth Cares (Legislation and Treatment Committees) Task Force on Alcoholism and Drug Abuse for Tarrant County Texas Association of Alcoholism and Drug Abuse Counselors (Honorary Lifetime Membership) Tarrant Council on Alcoholism and Drug Abuse, Board of Directors Department of Pharmacology and Pathology Graduate Students, M.S. and Ph.D. (Toxicology) University of North Texas Courses taught include: o PHARM 5050 Introduction to Toxicology o PHARM 5060 Experimental Toxicology
RESEARCH: o PHARM 5900 Special Problems o PHARM 5910 Special Problems o BMSB 5950 Thesis o Toxicology Section of Medical Pharmacology Irritation and Allergic Contact Sensitivity Evaluation of Hand Cleaner Research Chemicals, Inc., Fort Worth, TX Acute Ocular Irritation Evaluation of Formic Acid Fumes and the Albino Rabbit Texas Utilities Generating Co., Dallas, TX Analysis of Acetaminophen: Comparison of Fluorescence Polarization Immunoassay (FPIA) and High-Performance Liquid Chromatography (HPLC) Abbott Laboratories Excretion Pattern of Cannabinoids When Corrected for Creatinine Full Spectra GC/MS Identification of Delta-9-Carboxy-THC in Urine with the Finnigan ITS 40 Tarver, J., Wimbish, G., Chemical Ionization (CI) GC/MS Analysis of Underivatized Amphetamines Followed by Chiral Derivatization to Identity d- and l- Isomers with Ion Spectrometry. ABSTRACTS: Imidan and Trichlorfon Residues on Coastal Bermuda Grass; H.W. Dorough, G.H. Wimbish, Texas Agricultural Experimental Station Progress Report, 1965. Propranolol-Ethanol Interaction; G.H. Wimbish, R. Martz, R.B. Forney, Abstract, 1721 FASEB, p 519, 1972. Improved Chromatographic Separation of Opiates as TMS Derivatives by Formation of Oxine-TMS Derivatives of Hydrocodone and Hydromorphone; Randy Clouette, Gary H. Wimbish, Journal of Analytical Toxicology, Vol. 20, January/February 1996. Assay of Amphetamines by Rocher OnLine Immunoassay with Periodate Oxidation on the Hitachi 717; Wimbish, G.H. Pizzo, P., Nash, S., Wolford, D.R., SOFT Proceedings, Tampa, FL, 1994. The Determination of Codeine, Morphine, Hydrocodone, and Hydromorphone in Blood by Use of a Dual Derivatization Technique; Jeffery P. Brendler, MS, Randal E. Clouette, MS, Gary H. Wimbish, Ph.D., James C. Garriott, Ph.D.. Harrison Laboratories, Inc., Midland, TX, American Academy of Forensic Sciences, Feb. 1998.
REVIEWED PUBLICATIONS: The Determination of Amphetamine, Methamphetamine, and other Phenethylamines in Blood and Urine by a Dual Derivatization Technique; Randal E. Clouette, Jeffery P. Brendler, Gary H. Wimbish, and James C. Garriott, Harrison Laboratories, Inc., Midland, TX, American Academy of Forensic Sciences, Oct. 1997. M.A. Evans, G.H. Wimbish, L. Griffis, R. Martz, D.J. Brown, B.E. Rodda, L. Lemberger and R.B. Forney; Subjective Responses and Excretion Patterns of Dextroamphetamine After the Administration of Therapeutic Doses. Journal of Forensic Sciences, Vol. 22, No. 1, pp 197-201, 1977. G.H. Wimbish, R. Martz, R.B Forney; Combined Effects of Ethanol and Propranolol on Sleep Time in the Mouse. Life Sciences, Vol. 20, pp. 65-72, 1977. G.H. Wimbish; Arsenic Poisoning in Man. Osteopathic Medicine, Vol. 2, No, 11, pp 93-98, 1977. Wimbish G.H., Jones G.L., Amato R.J., Peyton G.A.: Comparison of the Anticonvulsant Activities and Brain Concentrations of Cyheptamide and Carbamazepine. Proc West Pharmacol Soc.; 23, pp. 75-79, 1980. M.F. Jones, Jones, G. L., R.J. Amato, G.A. Peyton, G.H. Wimbish;The Reassessment of the Anticonvulsant Activity of Diphenylsuccinimide., Proc West Pharmacol Soc.; Vol, 23, pp. 171-174, 1980. Kerri Hesley, G.H. Wimbish; Blood Lead and Zinc Protoporphyrin in Lead Industry Workers. American Industrial Hygiene Association Journal, Vol. 42, No. 1, pp. 42-46, Jan. 1981. Jones, G. L., Amato, R. J., Wimbish, G. H. and Peyton, G. A. Comparison of Anticonvulsant Potencies of Cyheptamide, Carbamazepine, and Phenytoin. Journal of Pharmaceutical Sciences, 70, pp. 618 620, 1981. Jones, G. L., Amato, R. J., Jones, M.F., Wimbish, G. H. and Peyton, G. A.; Diphenylsuccinimide: Anticonvulsant and Hydrophobic Properties, Journal of Pharmaceutical Sciences, 1983. Jones, G. L., Wimbish, G. H., McIntosh, W., Trese, T.; Phenytoin: Basic and Clinical Pharacology, Medical Research Review, Vol. 3, No. 4, pp 383-434, 1983. Lasley S.M., Wimbish G.H., Lane, J.D.; Valproate-Induced Accumulation of Gamma-aminobutyric Acid After Chronic Exposure to Inorganic Lead. Neurotoxicology. Vol. 7, No. 2, pp. 527-540. 1986. Wimbish, Gary, H., Ph.D.; Cannabinoid/Creatinine Ratio Improves Accuracy in Monitoring for Marijuana Re-Use, Forensic Urine Drug Testing, an AACC Education Newsletter for laboratories, March, 1989.
Wimbish, G.H., Wu, A.H.B., Onigbinde, T.A., Johnson, K.G.; Alcohol-Specific Cocaine Metabolites in Serum and Urine of Hospitalized Patients. Journal of Analytical Toxicology, Vol. 16, No. 21, p. 132., 1992. Wimbish, G.H., and Williams, T.L.; The Disposition of Amitriptyline After Acute Administration in the Dog. Special Bulletin T.I.A.F.T., Banff, Canada, July 27-31, 1987. Wimbish, G.H., Ph.D., and Johnson, K.G.; Full Spectra GC/MS Identification of Delta-9-Carboxy-THC in Urine with the Finnigan ITS40, Journal of Analytical Toxicology, 1990 Sep-Oct; 14(5); 292-5. Broussard, L.A., Presley, L.C., Pittman, T., Clouette, R., Wimbish, G.H.; Simultaneous Identification and Quantitation of Codeine, Morphine, Hydrocodone, and Hydromorphone in Urine as Trimethylsilyl and Oxime Derivatives by Gas Chromatography-Mass Spectrometry. Clinical Chemistry. 43:6, 1028-1037 (1997). Ashley M. Classen, D.O., FAOCA, Gary H. Wimbish, Ph.D., DABFT, and Thomas C. Kupiec, Ph.D.; Stability of Admixture Containing Morphine Sulfate, Bupivacaine Hydrochloride, and Clonidine Hydrochloride in an Implantable Infusion System, Journal of Pain and Symptom Management, Vol. 28, No. 6, pp. 603-611, Dec. 2004 PUBLICATIONS Wimbish, G.H.; The Test That Failed?. THE NARC OFFICER, p. 53-55, Oct. 1988. Wimbish, Gary, H., Ph.D.; Cannabinoid/Creatinine Ratio Improves Accuracy in Monitoring for Marijuana Re-Use, Forensic Urine Drug Testing, an AACC Education Newsletter for laboratories, March, 1989. Wimbish, Gary H., Ph.D.; A Critique of: The National Institute of Justice Study: A Comparison of Urinalysis Technologies for Drug Testing in Criminal Justice. Assay of Amphetamines by Rocher OnLine Immunoassay with Periodate Oxidation on the Hitachi 717; Wimbish, G.H. Pizzo, P., Nash, S., Wolford, D.R., SOFT Proceedings, Tampa, FL, 1994. BOOK REVIEW Safety and Quality in Food Proceedings of a DSA Symposium Wholesome Food for ALL. Views of the Animal Health Industries held in Brussels, 29-30 March 1984. Edited by DSA (Bureau European d Imformation pour le Development de la Sante Animals), Avenue de 11 Yser 19, B-1040 Brussels, Belgium. ISBN 0-444-42409-1 (vol. 17); 0-444-41703-6 (series). Drug Development Research 13:89 (1988). Patient Compliance in Medical Practice and Clinical Trials
Editors: Joyce A. Cramer, B.S. and Bert Spliker, Ph.D., M.D., Publisher: Raven Press Ltd.0 1185 Avenue of the Americas, New York, New York 10036. ISBN 0-88167-735-3. CONTRIBUTING AUTHOR TO BOOKS N.C. Jain, G.H. Wimbish: Caffeine. CRC Manual of Analytical Toxicology, pp 60-62, 1971. Wimbish, G.H. Monograph on: Therapeutic Drug Monitoring, Damon Clinical Laboratories, Jan. 1983. Wimbish, G.H., Jones, G.L.; Hydantoins- Toxicity of Hydantoins. The Handbook of Experimental Pharmacology, No. 74, pp 351-419, 1985.